Skip to main content

Corbus Pharmaceuticals Holdings, Inc.

CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001595097

In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Corbus Pharmaceuticals Holdings, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of CRBP: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders8680−6
Shares10.4M9.06M−1.37M (−13.1%)
Value$55.4M$62.5M+$7.13M (+12.9%)

New holders (15)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to CRBP in Q2 2025
InstitutionSharesValue% of portfolio
Y-Intercept (Hong Kong) Ltd20,437$141.0K0.00%
Baker Avenue Asset Management, LP20,000$138.0K0.00%
Marshall Wace, LLP19,871$137.1K0.00%
Squarepoint Ops LLC17,898$123.5K0.00%
Aster Capital Management (DIFC) Ltd16,509$113.9K0.03%
Corton Capital Inc.12,516$86.4K0.10%
Jain Global LLC12,369$85.3K0.00%
HRT Financial LP11,548$79.0K0.00%
Versant Capital Management, Inc601$4.15K0.00%
Raymond James Financial Inc434$2.99K0.00%
Nisa Investment Advisors, LLC287$1.98K0.00%
Essential Partners LLC109$7520.00%
Skopos Labs, Inc.41$2830.00%
IFP Advisors, Inc15$2130.00%
Scarborough Advisors, LLC6$410.00%

Sold out (21)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.